Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Beclomethasone for Intestinal GVHD
NCT00010283Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jul 2000
- Primary completion
- Jul 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of beclomethasone dipropionate in graft-versus-host disease (GVHD), sponsored by Fred Hutchinson Cancer Center. Started Jul 2000; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00010283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00010283.